spacer
spacer

Jump to: InterProScan Databases Documentation FTP site Help Advanced search

InterPro: IPR018521 DNA topoisomerase I, active site

Protein matchesHelp
UniProtKB
Matches:
230 proteins
AccessionHelp IPR018521 TopoI_AS
TypeHelp Active_site
SignaturesHelp
InterPro RelationshipsHelp
Found in IPR001631 DNA topoisomerase I, C-terminal
IPR011010 DNA breaking-rejoining enzyme, catalytic core
IPR013499 DNA topoisomerase I, C-terminal, eukaryotic-type
IPR014727 DNA topoisomerase I, catalytic core, alpha/beta subdomain, eukaryotic-type
GO Term annotationHelp
Process GO:0006265 DNA topological change
Function GO:0003677 DNA binding
GO:0003917 DNA topoisomerase type I activity
InterPro annotation
BioMart Logo Entry Details in BioMart
AbstractHelp

DNA topoisomerases regulate the number of topological links between two DNA strands (i.e. change the number of superhelical turns) by catalysing transient single- or double-strand breaks, crossing the strands through one another, then resealing the breaks. These enzymes have several functions: to remove DNA supercoils during transcription and DNA replication; for strand breakage during recombination; for chromosome condensation; and to disentangle intertwined DNA during mitosis [1, 2]. DNA topoisomerases are divided into two classes: type I enzymes (EC:5.99.1.2; topoisomerases I, III and V) break single-strand DNA, and type II enzymes (EC:5.99.1.3; topoisomerases II, IV and VI) break double-strand DNA [3].

Type I topoisomerases are ATP-independent enzymes (except for reverse gyrase), and can be subdivided according to their structure and reaction mechanisms: type IA (bacterial and archaeal topoisomerase I, topoisomerase III and reverse gyrase) and type IB (eukaryotic topoisomerase I and topoisomerase V). These enzymes are primarily responsible for relaxing positively and/or negatively supercoiled DNA, except for reverse gyrase, which can introduce positive supercoils into DNA.

DNA topoisomerase I (EC:5.99.1.2) [4, 5, 6, 7] is one of the two types of enzyme that catalyze the interconversion of topological DNA isomers. Type I topoisomerases act by catalyzing the transient breakage of DNA, one strand at a time, and the subsequent rejoining of the strands. When a eukaryotic type 1 topoisomerase breaks a DNA backbone bond, it simultaneously forms a protein-DNA link where the hydroxyl group of a tyrosine residue is joined to a 3'-phosphate on DNA, at one end of the enzyme-severed DNA strand. In eukaryotes and poxvirus topoisomerases I, there are a number of conserved residues in the region around the active site tyrosine [6].

More information about this protein can be found at Protein of the Month: DNA Topoisomerase [8].

Structural linksHelp
SCOP: a.2.8.1 , d.163.1.2
Database linksHelp
Enzyme: EC:5.99.1.2

Taxonomic coverageHelp

Overlapping InterPro entriesHelp
IPR018521 Numbers of overlapping proteins Average numbers of overlapping amino acids

Example proteinsHelp
O17966 DNA topoisomerase 1

P04786 DNA topoisomerase 1

P11387 DNA topoisomerase 1

P30189 DNA topoisomerase 1

Q04750 DNA topoisomerase 1

More proteins


Example Proteins Key


InterPro entry accession number/name and structure databases Colour code
IPR014727 DNA topoisomerase I, catalytic core, alpha/beta subdomain, eukaryotic-type
IPR011010 DNA breaking-rejoining enzyme, catalytic core
IPR008336 DNA topoisomerase I, DNA binding, eukaryotic-type
IPR018521 DNA topoisomerase I, active site
IPR001631 DNA topoisomerase I, C-terminal
IPR013030 DNA topoisomerase I, DNA binding, mixed alpha/beta motif, eukaryotic-type
IPR013500 DNA topoisomerase I, catalytic core, eukaryotic-type
IPR009054 DNA topoisomerases I, dispensable insert, eukaryotic-type
IPR013499 DNA topoisomerase I, C-terminal, eukaryotic-type
IPR014711 DNA topoisomerase I, catalytic core, alpha-helical subdomain, eukaryotic-type
PDB Chain
ModBase
CATH Domain
SWISS-MODEL
SCOP Domain

PublicationsHelp
1. Wang JC.
Cellular roles of DNA topoisomerases: a molecular perspective.
Nat. Rev. Mol. Cell Biol. 3 430-40 2002 [PubMed: 12042765]
http://dx.doi.org/10.1038/nrm831
2. Champoux JJ.
DNA topoisomerases: structure, function, and mechanism.
Annu. Rev. Biochem. 70 369-413 2001 [PubMed: 11395412]
http://dx.doi.org/10.1146/annurev.biochem.70.1.369
3. Gadelle D, Filee J, Buhler C, Forterre P.
Phylogenomics of type II DNA topoisomerases.
Bioessays 25 232-42 2003 [PubMed: 12596227]
http://dx.doi.org/10.1002/bies.10245
4. Sternglanz R.
DNA topoisomerases.
Curr. Opin. Cell Biol. 1 533-5 1989 [PubMed: 2560656]
http://dx.doi.org/10.1016/0955-0674(89)90016-1
5. Sharma A, Mondragon A.
DNA topoisomerases.
Curr. Opin. Struct. Biol. 5 39-47 1995 [PubMed: 7773745]
http://dx.doi.org/10.1016/0959-440X(95)80007-N
6. Lynn RM, Bjornsti MA, Caron PR, Wang JC.
Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I.
Proc. Natl. Acad. Sci. U.S.A. 86 3559-63 1989 [PubMed: 2542938]
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=2542938&action=stream&blobtype=pdf
7. Roca J.
The mechanisms of DNA topoisomerases.
Trends Biochem. Sci. 20 156-60 1995 [PubMed: 7770916]
http://dx.doi.org/10.1016/S0968-0004(00)88993-8
8. McDowall J.
Protein of the Month: DNA Topoisomerase.
2006

Additional ReadingHelp
Chrencik JE, Burgin AB, Pommier Y, Stewart L, Redinbo MR.
Structural impact of the leukemia drug 1-beta-D-arabinofuranosylcytosine (Ara-C) on the covalent human topoisomerase I-DNA complex.
J. Biol. Chem. 278 2003 12461-6 [PubMed: 12533542]
http://dx.doi.org/10.1074/jbc.M212930200
Chrencik JE, Staker BL, Burgin AB, Pourquier P, Pommier Y, Stewart L, Redinbo MR.
Mechanisms of camptothecin resistance by human topoisomerase I mutations.
J. Mol. Biol. 339 2004 773-84 [PubMed: 15165849]
http://dx.doi.org/10.1016/j.jmb.2004.03.077
Interthal H, Quigley PM, Hol WG, Champoux JJ.
The role of lysine 532 in the catalytic mechanism of human topoisomerase I.
J. Biol. Chem. 279 2004 2984-92 [PubMed: 14594810]
http://dx.doi.org/10.1074/jbc.M309959200
Staker BL, Feese MD, Cushman M, Pommier Y, Zembower D, Stewart L, Burgin AB.
Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex.
J. Med. Chem. 48 2005 2336-45 [PubMed: 15801827]
http://dx.doi.org/10.1021/jm049146p
Ioanoviciu A, Antony S, Pommier Y, Staker BL, Stewart L, Cushman M.
Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis.
J. Med. Chem. 48 2005 4803-14 [PubMed: 16033260]
http://dx.doi.org/10.1021/jm050076b
spacer
spacer
InterPro 23.1